In Patients with a Chronic Type B Dissection, Does Endovascular Treatment Reduce Long Term Complications?


P (patients)

I (intervention)

C (comparator group)

O (outcomes measured)

Patients with Chronic Type B dissection

Endovascular treatment

Medical management (for uncomplicated type B dissection)

Open surgical repair (complicated type B dissection)

30 day mortality, early CVA and spinal cord ischemia (SCI), long-term survival, aortic event-free survival and rate of aortic re-interventions.




Table 2.2
Results for TEVAR in chronic complicated Type B aortic dissection




































































































Author, year (ref.#)

n

30 day mortality N (%)

Early CVA N (%)

Early SCI N (%)

Mean f/up (m)

Survival (%)

Aortic event freedom rate
 
Aorta related death, reintervention, expansion free (%)

Aorta related death free (%)

Prospective nonrandomized trials

Virtue registry (2011, 2014) [10, 11]

50

0

0

1 (3.8)

36

1 year: 96

3 years: 74

1 year: 88

3 years: 68

1 year: 91.3

3 years: 74

Case series

Alves (2009) [13]

61

2 (3.3)

0

0

35.9

3 years: 94

3 years: 78

n/a

Parsa (2011) [16]

51

0

0

0

27

5 years: 77.7

5 years:77.3

5 years: 98

Kang (2011) [17]

76

4 (5)

1 (1.3)

0

34

1 year: 86

3 years: 80

1 year: 72

3 years: 59

1 year: 89

3 years: 86

Andacheh (2012) [18]

73

10 (14)

1 (1.3)

1 (1.3)

18

1 year: 81

1 year: 85

1 year: 86

Mani (2012) [19]

58

3 (5.2)

0

1 (1.7)

n/a

1 year: 89

3 years: 64

1 year: 85

3 years: 71
 

Cumulative

369

5.6 %

0.4 %

1.1 %
     


SCI spinal cord ischemia, CVA cerebral vascular accident, f/up follow up



Table 2.3
Results for medical treatment in chronic uncomplicated Type B aortic dissection



































































Author, year (ref.#)

n

30 days mortality N (%)

Early CVA N (%)

Early SCI N (%)

Mean f/up (m)

Survival (%)

Aortic event freedom rate
             
Aorta related death, reintervention, expansion free (%)

Aorta related death free (%)

Prospective randomized controlled trials

Nienaber INSTEAD (2009, 2013) [8, 9]

68

0

0

0

69

1 year: 82.5

15 years: 80.7 years: 97

1 year: 82.5

5 years: 53.9

1 year: 97

5 years: 80.7

Prospective nonrandomized trials

Jia (2013) [12]

68

0

0

0

69

1 year: 97

5 years: 80.7

1 year: 82.5

5 years: 53.9

1 year: 97

5 years: 80.7

Cumulative

163

0

0

0
       



Table 2.4
Results for TEVAR in chronic uncomplicated Type B aortic dissection





























































































Author, year (ref.#)

n

30 days mortality N (%)

Early CVA N (%)

Early SCI N (%)

Mean f/up (m)

Survival (%)

Aortic event freedom rate
             
Aorta related death, reintervention, expansion free (%)

Aorta related death free (%)

Prospective randomized controlled trials

Nienaber INSTEAD (2009, 2013) [8, 9]

72

2 (2.8)

1 (1.4)

2 (2.9)

69

1 year: 91.3

5 years: 91.3

1 year: 83.3

5 years: 73

1 year: 94.2

5 years: 93.1

Prospective nonrandomized trials

Zipfel Restore registry (2011) [20]

51

3 (5)

0

2 (3.9)

10

N/a

n/a

n/a

Jia (2013) [12]

208

0

0

2 (0.9)

28.5

2 years: 87.5

4 years: 82.7

2 years: 87.8

4 years: 78.8

2 years: 91.6

4 years: 88.1

Case series

Kim (2009) [14]

72

0

0

0

64.4

5 years: 92

5 years: 83.9

5 years: 98.3

Xu (2009) [15]

84

1 (1.2)

0

0

33.2

3 years: 91.7

5 years: 84.4

7 years: 75.2

Kim (2009) [14]

72

0

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 11, 2017 | Posted by in CARDIOLOGY | Comments Off on In Patients with a Chronic Type B Dissection, Does Endovascular Treatment Reduce Long Term Complications?

Full access? Get Clinical Tree

Get Clinical Tree app for offline access